Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Medicare"


25 mentions found


Biogen's Alzheimer's drug stumbled through testing but will become available in the US for $56,000. The arrival of the first new Alzheimer's drug in two decades should have been a moment of celebration. Collier was diagnosed in 2008 with Alzheimer's disease and was part of a clinical trial at Brigham and Women's Hospital. Though Knopman was against Aduhelm's approval, he's come around to the idea that it might not spell disaster for other drug trials. Chief Medical Officer Hans Moebius led the research team that developed the last major Alzheimer's drug, Namenda, which was approved in 2003.
Persons: Dr, David Knopman, Knopman, Biogen, Charles W, Collier, Scott McGinnis, Suzanne Kreiter, Aduhelm, Michel Vounatsos, Ronny Gal, That's, Charles Flagg, Charles Krupa, Alzheimer's, James Brewer, Jefferies, Andrew Tsai, George Perry, Perry, Thomson, Michael Greicius, Caleb Alexander, John Dwyer, drugmakers, he's, who've, that's, Hans Moebius, Moebius isn't, Dwyer Organizations: US Food and Drug Administration, Mayo Clinic, FDA, Brigham, Women's, Boston Globe, Getty, Alzheimer's Association, Caring, for Clinical, Medicare's, Butler Hospital, Associated Press Medical, University of California, University of Texas, Thomson Reuters, University of Southern, New York Times, Athira Pharma Locations: Providence , Rhode Island, University of California San Diego, San Antonio, Mexico City, University of Southern California, Seattle
Clover Health joins meme stock club. For these retail investors, meme stocks fulfill three functions:Punishing short sellers. Clover Health short sellers, who believed the stock was overvalued , were down $438 million in mark-to-market losses. Clover Health short sellers, who believed the stock was , were down in mark-to-market losses. Our Digital Health analyst's take: Clover can capitalize on its share price surge to fund product development and expansion.
Persons: Reddit, Clover, Redditors Organizations: Clover Health, Digital Health, Clover ., Intelligence, Bloomberg, Digital, GameStop, Medicare, Medicaid Services, Health, Gamestop, Oscar Health
GameStop tumbles, Clover Health rises in 'meme stock' rollercoaster
  + stars: | 2021-06-10 | by ( Reuters Staff | ) www.reuters.com sentiment -1.00   time to read: +1 min
June 10 (Reuters) - Shares of GameStop fell 7.6% and Clover Health Investments jumped 5.9% in early deals on Thursday, setting the stage for another rollercoaster session for stocks favored by small-time investors on social media platforms. Clover Health, which had a short interest of 43.5% of free float as of Tuesday, was up 5.9% at around $17.92 before the bell. In the past two weeks, the so-called “meme stocks” have received $1.27 billion of retail inflows, Vanda Research said on Wednesday. That matched their peak in January, when the surge in GameStop shares squeezed short sellers and further boosted the stock price. Shares of AMC Entertainment were down 6.0%, while prison operator Geo Group - the latest “meme stock” - slumped 8.5% after surging 38% on Wednesday.
Persons: Vanda, Sagarika, Sriraj Kalluvila Organizations: GameStop, Clover Health Investments, Wednesday, Medicare, Clover Health, AMC Entertainment, U.S . Securities, Exchange Commission, SEC, Vanda Research, Geo Locations: Bengaluru
GameStop tumbles, Clover Health rises in 'meme stock' roller coaster
  + stars: | 2021-06-10 | by ( ) www.reuters.com + 0.00   time to read: +2 min
A person walks past a GameStop in the Manhattan borough of New York City, New York, U.S., January 29, 2021. REUTERS/Carlo Allegri/File PhotoShares of GameStop Corp (GME.N) fell 7% and Clover Health Investments Corp (CLOV.O) jumped 6.4% in early deals on Thursday, setting the stage for another roller coaster session for stocks favored by small-time investors on social media platforms. Shares of cinema operator AMC Entertainment Holdings Inc (AMC.N) were down 4.1%, while prison operator Geo Group Inc (GEO.N), the latest "meme stock", slumped 8.8%, after surging more than 38% on Wednesday. In the past two weeks, the so-called "meme stocks" have received $1.27 billion of retail inflows, Vanda Research said on Wednesday. That matched their peak in January, when the surge in GameStop shares squeezed short sellers and further boosted the stock price.
Persons: Carlo Allegri, Inc's, Edward Moya, Moya, Clover, Vanda Organizations: GameStop, REUTERS, GameStop Corp, Clover Health Investments Corp, Wednesday, ContextLogic Inc, Clean Energy Fuels Corp, AMC Entertainment Holdings Inc, Geo Group Inc, Medicare, AMC, U.S . Securities, Exchange Commission, SEC, Vanda Research, Thomson Locations: Manhattan, New York City , New York, U.S
GameStop tumbles, other "meme stocks" falter after big runups
  + stars: | 2021-06-10 | by ( ) www.reuters.com + 0.00   time to read: +2 min
A person walks past a GameStop in the Manhattan borough of New York City, New York, U.S., January 29, 2021. REUTERS/Carlo Allegri/File PhotoShares of GameStop Corp (GME.N) fell more than 17% on Thursday and other so-called meme stocks also declined, setting the stage for another roller-coaster session for stocks favored by retail investors on social media platforms. AMC shares were off around 11%. In the past two weeks, the so-called "meme stocks" have received $1.27 billion of retail inflows, Vanda Research said on Wednesday. That matched their peak in January, when the surge in GameStop shares squeezed short sellers and further boosted the stock price.
Persons: Carlo Allegri, Inc's, Edward Moya, Clover, Vanda Organizations: GameStop, REUTERS, GameStop Corp, Wedbush Securities, AMC Entertainment Holdings, Clover Health Investments Corp, Geo Group Inc, AMC, Medicare, U.S . Securities, Exchange Commission, SEC, Vanda Research, Thomson Locations: Manhattan, New York City , New York, U.S
GameStop falls 25% on potential share sale, other 'meme stocks' falter
  + stars: | 2021-06-10 | by ( ) www.reuters.com + 0.00   time to read: +3 min
A person walks past a GameStop in the Manhattan borough of New York City, New York, U.S., January 29, 2021. REUTERS/Carlo Allegri/File PhotoShares of GameStop Corp (GME.N) fell 25% on Thursday and other so-called meme stocks also declined in a sell-off that hit a broad range of stocks favored by retail investors on social media platforms. "It appears that other companies, like GameStop, are hoping to follow AMC’s lead by issuing shares and otherwise profit from the meme stocks run up,” Ablin said. In the past two weeks, the so-called "meme stocks" have received $1.27 billion of retail inflows, Vanda Research said on Wednesday. That matched their peak in January, when the surge in GameStop shares squeezed short sellers and further boosted the stock price.
Persons: Carlo Allegri, Inc's, Jack Ablin, ” Ablin, Clover, Vanda Organizations: GameStop, REUTERS, GameStop Corp, AMC Entertainment Holdings, Clover Health Investments Corp, Geo Group Inc, AMC, Cresset Capital, , Wedbush Securities, Medicare, U.S . Securities, Exchange Commission, SEC, Vanda Research, Thomson Locations: Manhattan, New York City , New York, U.S
Biogen's pricy new Alzheimer's drug, Aduhelm, could cost Medicare billions of dollars a year, according to an analysis published Thursday by the non-profit Kaiser Family Foundation. Biogen has said it expects about 80% of Alzheimer's patients to be covered by Medicare, the federal health insurance program for the elderly. It is still unclear how many Medicare beneficiaries will take Biogen's drug, but even a conservative estimate would lead to a "substantial increase" in Medicare spending, according to KFF. In 2017, nearly 2 million Medicare beneficiaries used one or more Alzheimer's treatments covered under Medicare Part D, according to KFF, which analyzed claims data. The company has committed to not raising the price of the new drug over the next four years.
Persons: Biogen's, Biogen, KFF, Umer Raffat, you've Organizations: Family Foundation, The, Drug Administration, Medicare, Aduhelm, FDA, Wall Street Locations: Massachusetts
The F.D.A.’s decision to green-light it, announced Monday, marked the first approval of an Alzheimer’s treatment in 18 years. But since at least last fall, several respected experts, including some Alzheimer’s doctors who worked on the aducanumab clinical trials, have said the available evidence raised significant doubts about whether the drug is effective. Beyond their conviction that the existing evidence for Aduhelm’s benefit is weak, the advisory committee members who resigned — as well as several prominent Alzheimer’s experts — objected to two major aspects of the F.D.A.’s approval decision. approved the drug for a much broader group of patients — anyone with Alzheimer’s — than many experts were anticipating. The clinical trials tested the drug only on patients with early-stage Alzheimer’s or mild cognitive impairment from the disease.
Persons: Kesselheim, , , Alzheimer’s Organizations: Medicare
New Reddit darling Clover Health jumps 13%
  + stars: | 2021-06-09 | by ( Reuters Staff | ) www.reuters.com sentiment -0.93   time to read: +1 min
FILE PHOTO: The New York Stock Exchange is pictured in the Manhattan borough of New York City, New York, U.S., April 16, 2021. REUTERS/Carlo Allegri/File Photo(Reuters) - Shares of Clover Health Investments Corp jumped 13.3% in early deals on Wednesday, a day after small-time traders on online discussion forums sent its stock zooming 86% to a record high. Medicare-backed insurance seller Clover Health, among the most shorted stocks across U.S. exchanges, has emerged as the new favorite of individual traders who had previously hyped shares of AMC Entertainment Holdings Inc and GameStop Corp in forums such as Reddit’s WallStreetBets. Clover Health was one of the most heavily traded stocks before the bell after logging its highest trading volume on U.S. exchanges on Tuesday. Shares of video game retailer GameStop were up 2.3%, while AMC and U.S.-listed shares of BlackBerry Ltd fell 4.1% and 1.0%, respectively.
Persons: Carlo Allegri Organizations: New York Stock, REUTERS, Clover Health Investments Corp, Medicare, Clover Health, AMC Entertainment Holdings Inc, GameStop Corp, GameStop, AMC, BlackBerry Ltd Locations: Manhattan, New York City , New York, U.S
Reddit darling Clover Health set for record high in latest 'meme stock' rally
  + stars: | 2021-06-09 | by ( Reuters Staff | ) www.reuters.com sentiment -1.00   time to read: +1 min
FILE PHOTO: The New York Stock Exchange is pictured in the Manhattan borough of New York City, New York, U.S., April 16, 2021. Medicare-backed insurance seller Clover Health is a new favorite of small-time traders who had previously sent shares of GameStop Corp and AMC Entertainment Holdings soaring using social media channels such as Reddit’s WallStreetBets. On trading-focused site Stocktwits, message volume related to Clover Health more than doubled and 95.4% of the messages reflected a positive sentiment toward the heavily shorted stock. Clover Health was also among the most traded stocks premarket after logging the highest trading volume on U.S. exchanges on Tuesday. Among other “meme stocks”, shares of video-game retailer GameStop were up 2.7% on Wednesday, while AMC and security solutions provider BlackBerry’s U.S.-listing fell 7.4% and 5.4%, respectively.
Persons: Carlo Allegri, Melvin Capital Organizations: New York Stock, REUTERS, Clover Health Investments Corp, Medicare, Clover, GameStop Corp, AMC Entertainment Holdings, Clover Health, GameStop, AMC, Lordstown Motors Corp Locations: Manhattan, New York City , New York, U.S
On Medicare and Need Dental Work? Beware a Big Bill.
  + stars: | 2021-06-09 | by ( Mark Miller | ) www.nytimes.com sentiment -1.00   time to read: +2 min
She retired nine years ago as the executive director of a nonprofit community health and home care agency. Coverage for dental, visual and hearing care has moved to the front burner this year as part of a broader discussion about Medicare expansion in Washington. Vision loss and hearing loss are associated with a higher risk of falls, depression and cognitive impairment, and hearing loss with higher rates of hospitalization. Federal data shows that 19 percent of older adults have untreated tooth decay and another 19 percent have complete tooth loss. Two-thirds of Americans 70 and older have hearing loss.
Persons: “ I’m, , Biden, Amber Willink Organizations: Health Affairs, University of Sydney Locations: Washington, Australia
Clover Health soars as 'meme stock' rally expands
  + stars: | 2021-06-08 | by ( ) www.reuters.com + 0.00   time to read: +4 min
read moreShort interest in Clover Health is at 49.10 million shares, or 43.5% of the float, Ihor Dusaniwsky, managing director of predictive analytics at S3 said on Tuesday. Shorts have been building their position in Clover Health as its stock price has been rallying, Dusaniwsky said. Call options speculating on the stock climbing all the way to $30 were among some of the most heavily traded contracts in recent days. With Clover options trading in heavy volume, the gamma picture can quickly change as investors take new positions. Electric-truck maker Workhorse Group Inc (WKHS.O) shares gained 17.4%, while AMC was down 0.8%, and Carlotz (LOTZ.O) climbed 23.3%.
Persons: Carlo Allegri, Clover, Thomas Hayes, Dusaniwsky, , Jay Wolberg, Wolberg Organizations: AMC, REUTERS, Clover Health Investments Corp, Medicare, Great, Capital, GameStop Corp, AMC Entertainment Holdings Inc, U.S . Securities, Exchange Commission, Clover Health, Trade, Clover, GameStop, Thomson Locations: Manhattan, New York City , New York, U.S, New York
We just got the first new Alzheimer's drug in nearly 2 decades
  + stars: | 2021-06-08 | by ( Lydia Ramsey Pflanzer | ) www.businessinsider.com sentiment -1.00   time to read: +1 min
Let's get to it...Dr. William Burke goes over a PET brain scan at Banner Alzheimers Institute in Phoenix. Biogen's drug was tested against carriers of the APOE gene, which is linked to Alzheimer's, and non-carriers. Matt York/Associated PressThe FDA on Monday approved the first new Alzheimer's disease treatment in nearly two decades. Get the full story>>Maree Valenta, who has Alzheimer's disease, undergoes a scan to detect early Alzheimer's in 2004. Photo by Fairfax Media via Getty Images/Fairfax Media via Getty Images via Getty ImagesThe FDA just approved a new Alzheimer's disease drug that targets a plaque that builds up in some patients' brains.
Persons: I'm Lydia Ramsey Pflanzer, Let's, Dr, William Burke, Matt York, Biogen, Valenta, Lydia Organizations: Insider Healthcare, Banner Alzheimers Institute, Associated Press, FDA, Iora, Fairfax Media, Getty Images, Getty, Medicare Locations: Phoenix
Biogen on Tuesday faced tough questions from Wall Street analysts over the $56,000 annual cost of its newly approved Alzheimer's drug, Aduhelm – a price tag executives are calling "fair" and "responsible." Shares of Biogen surged 38% on Monday after the FDA announced it approved the company's drug, scientifically known as aducanumab. That's the wholesale price, and the out-of-pocket cost patients will actually pay will depend on their health coverage. Biogen executives said the total price figure for the new treatment is "substantiated" by the value it is expected to bring to patients, caregivers and society. The company has committed to not raising the price of the new drug over the next four years.
Persons: Aduhelm, Jeff Preis, Umer Raffat, you've, Morgan, Cory Kasimov, Michel Vounatsos Organizations: Wall Street, FDA, Alzheimer's Association, CNBC, Medicare Locations: Massachusetts, U.S
REUTERS/Brian SnyderFor Bill McKay, 69, of Haslett, Michigan, the U.S. approval of Biogen Inc's (BIIB.O) new Alzheimer's drug on Monday offers hope that the veteran of 29 marathons can keep on running. For his wife, Jill McKay, 66, an office manager, it offers the hope that he will not get lost along the way. The drug, called Aduhelm, is the first treatment ever approved to target a cause of Alzheimer's, with the aim of slowing progression of the mind-robbing disease. The hospital arranged for Reuters to speak with the couple and Dr. Leahy. "We have an appointment with Dr Leahy next week," Jill McKay said.
Persons: Brian Snyder, Bill McKay, Biogen, Jill McKay, Alzheimer's, Dr, Cara Leahy, Leahy, Dr Leahy Organizations: REUTERS, Memorial Healthcare, Reuters, U.S . Food, Drug Administration, FDA, U.S, Medicare, Thomson Locations: Cambridge , Massachusetts, U.S, Haslett , Michigan, Owosso , Michigan
FDA Approves First New Alzheimer’s Drug in Nearly Two Decades
  + stars: | 2021-06-07 | by ( Joseph Walker | ) www.wsj.com + 0.00   time to read: +13 min
The first drug promising to slow the memory-robbing march of Alzheimer’s disease was approved by U.S. health regulators, a watershed after years of research and billions of dollars in investment. New Treatment for Alzheimer’sBiogen's drug aducanumab may help slow damage to the brain caused by the degenerative disease. How Alzheimer’s affects the brainA prominent scientific theory holds that in Alzheimer's disease, naturally occurring proteins bind together into clumps called amyloid plaques. “This historic moment is the culmination of more than a decade of groundbreaking research in the complex field of Alzheimer’s disease,” said Biogen Chief Executive Michel Vounatsos. The FDA last approved a new Alzheimer’s drug in 2003.
Persons: Alzheimer’s, , Michel Vounatsos, David A ., Alzheimer’s —, Patrizia Cavazzoni, Doctors, Richard Isaacson, Dr, Isaacson, “ There’s, Biogen, aducanumab, Cavazzoni, Jason Karlawish, I’ve, Karlawish, Cigna, , Steve Miller, Miller, , Biogen’s, Vounatsos, ” Mr, Joseph Walker Organizations: U.S . Food, Drug Administration, Doctors, Cigna Corp, Biogen Inc, Institute for Clinical, Cigna, U.S . Centers for Disease Control, Associated, FDA, Aduhelm, Weill Cornell Medicine, New York - Presbyterian, Daily, American Medical Association, University of Pennsylvania, Penn Memory, Medicare, drugmakers Locations: U.S, Alzheimer’s, Cambridge, New York, coinsurance, joseph.walker
U.S. regulators gave the green light to the drug known as aducanumab, the first such approval of any drug that promises to slow the progression of the fatal disease. Accordingly, Wall Street thinks Biogen has a blockbuster on its hands. For Biogen, that prospective growth is badly needed: the company expects to book roughly $10.6 billion in total revenue this year. Sales of its top-selling multiple sclerosis drug Tecfidera are falling as generic competition comes online in the U.S. For starters, patients will require testing before receiving the drug that can result in hefty out-of-pocket costs for patients insured by Medicare.
Persons: Biogen Organizations: Medicare Locations: U.S
About six million people in the United States and roughly 30 million globally have Alzheimer’s, a number expected to double by 2050. Currently, five medications approved in the United States can delay cognitive decline for several months in various Alzheimer’s stages. Experts anticipate there will be tremendous demand for aducanumab from patients desperate to try any approved medication. Because Alzheimer’s primarily affects older people, most costs are expected to fall to Medicare’s Part B program. The trials were stopped early by a data monitoring committee that found aducanumab didn’t appear to be showing any benefit.
Persons: aducanumab, Biogen, , Lon Schneider Organizations: Wall Street, Medicare, Disease, University of Southern Locations: United States, California, University of Southern California
Primary care company One Medical plans to acquire competitor Iora Health in a $2.1 billion deal. It's the latest example of primary care companies chasing seniors. Primary care company One Medical plans to acquire competitor Iora Health for about $2.1 billion in a bid to reach a growing senior population, the company said on Monday. Iora Health is focused on senior patients in risk-sharing health plans, including through Medicare Advantage and Medicare direct contracting. It's also part of a broader effort by primary care companies to embrace new ways of paying doctors.
Persons: Amir Dan Rubin, It's, Iora, Rubin Organizations: Iora, Medicare, Health, Oak Locations: Boston
zimmytws | iStock | Getty ImagesPresident Joe Biden's 2022 budget could give the Social Security Administration a $1.3 billion — or 9.7% — boost in funding. The proposed increase comes as the Social Security Administration expects to pay more than $1.2 trillion in both Social Security and Supplemental Security Income benefits to more than 74 million beneficiaries in 2022. The money would allow the Social Security Administration to pursue a host of improvement efforts, Social Security Administration Commissioner Andrew Saul said in the agency's budget overview. Legacy problems to solveThe group's concerns about Social Security customer service date back to before the pandemic, according to Adcock. Rep. John Larson, D-Conn., who serves as chairman of the House Ways and Means' subcommittee on Social Security, has voiced his support.
Persons: Joe Biden's, Andrew Saul, Saul, Medicare —, Dan Adcock, Biden, Roth, Adcock, John Larson, Conn, they're, Larson, Donald Trump's Organizations: iStock, Getty, Social Security, Social Security Administration, National Committee, Preserve Social Security, Medicare, Finance, Democratic Locations: Adcock
The plaque is generally detected through a special imaging test called a positron emission tomography or PET scan. This is a new way of assessing Alzheimer's patients. Alzheimer's patients almost never got PET scans up to this point, neurologists told Insider. At $56,000 a year, on average, Aduhelm could cost Medicare enrollees roughly $11,200. patient undergoes a positron emission tomography PET scan at the PET Technology Centre based at the Ivanovo Region Cancer Centre in Russia.
Persons: Marwan Sabbagh, Sabbagh, drugmaker Biogen, it's, neurologists, they're, there's, Steve Miller, Charles DeCarli, John Olichney, Lezlie, Sharon Jhawar, Jhawar, Desiree Otenti, Otenti, Charles Flagg, Charles Krupa, Casey Schwarz, Robert Egge, Vladimir Smirnov, James Brewer wasn't, Aduhelm, Brewer Organizations: FDA, Medicare, Cleveland Clinic, Drug Administration, Biogen, of Southern, Centers, CMS, Disease, Lezlie Sterling, Sacramento Bee, Tribune, Service, Getty Images, Humana, Medicaid Services, of Massachusetts, Alzheimer's, Butler Hospital, Associated Press, Kaiser Family Foundation, Alzheimer's Association, Commonwealth Fund, PET Technology, Ivanovo Region Cancer Centre, Getty, of California Locations: of Southern California, mull, Sacramento, Calif, California, Providence, R.I, That's, Ivanovo Region, Russia, San Diego, North Platte , Nebraska, Lincoln , Nebraska
After jumping more than 50%, Biogen shares closed up 38.3% at $395.85 - their highest closing level in over six years. "This is good news for patients with Alzheimer's disease. We've not had a disease modifying therapy approved ever," said Dr. Ronald Petersen, an Alzheimer's disease expert at the Mayo Clinic. Under that pathway, Biogen is required to conduct a confirmatory clinical trial, but has several years to do so, she said. Other doctors said clinical trial results were inconsistent and more proof was needed.
Persons: Biogen, Eisai, We've, Ronald Petersen, It's, Peterson, Patrizia Cavazzoni, I'm, Caleb Alexander, Johns Hopkins, Brian Snyder, Aducanumab, Steve Miller, Miller, Howard Fillit, Alzheimer’s, Eli Lilly Organizations: Mayo Clinic, Drug Administration, FDA's Center, Drug, REUTERS, Brian Snyder Read More, U.S, Cigna Corp, Medicare, FDA, Discovery Foundation, Alzheimer’s Association, Wall Street, Street, AC Immune SA, Sciences, Axsome Therapeutics, Thomson Locations: United States, Cambridge , Massachusetts, U.S, Brian Snyder Read More U.S
WASHINGTON — When President Barack Obama abandoned a public insurance option to win moderate support for the Affordable Care Act in 2009, progressives were enraged. Making a public option the law would require significant legislative work to flesh out. Senate Democratic aides working on a public option acknowledge that the drug issue has more momentum for now. It’s that it’s not ready for prime time,” Frederick Isasi, executive director of the health care advocacy group Families USA, said. There is some movement on a public option at the state level, where Nevada is set to create a new government insurance plan.
Persons: WASHINGTON, Barack Obama, Joe Biden, , , Alex Lawson, Sen, Patty Murray, Frank Pallone, John Moore, Shalanda Young, Susan Walsh, Tim Kaine, Virginia, Michael Bennet of Colorado, Biden, ” Kaine, ” Ben Nelson, ” Nelson, Bernie Sanders, ” Larry Levitt, Nancy Pelosi, “ It’s, it’s, ” Frederick Isasi, Joe Manchin, Biden’s, ” Sen, Chris Murphy, Conn Organizations: Affordable, NBC News, White, Social Security, Democratic, Remote Area Medical, Medicare, Progressives, Congressional Progressive Caucus, Family Foundation, ACA Locations: Wise, Va, there’s, Nebraska, Nevada, Washington
Covid Live Updates: U.S. Nursing Home Deaths Drop Sharply
  + stars: | 2021-06-03 | by ( Brillian Bao | Yves De Jesus | ) www.nytimes.com + 0.00   time to read: +10 min
Nursing Home Deaths Drop Sharply The pandemic death toll in such facilities has plummeted from a peak of 5,000 a week to less than 300. U.S. nursing home deaths fall sharply as older Americans are vaccinated. Since vaccines have arrived, deaths in nursing homes, in particular, have fallen significantly. The funds were sought to buy additional vaccine doses for the countries least able to afford them and to invest in new vaccine candidates. To date, 19.3 million doses of Pfizer’s vaccine have come to Canada, compared with 5.7 million doses of Moderna and 2.8 million Astra Zeneca shots.
Persons: Kristian Thacker, Coronavirus, , Cindy Prins, , Prins, hesitancy, David Gifford, ” Brillian Bao, Sweden —, Gavi, Seth Berkley, Tedros Adhanom Ghebreyesus, Berkley, Kamala Harris, Ms, Harris, Melinda Gates, Carlos Osorio Organizations: . Nursing, ., The New York Times, New York Times, Times, University of Florida, Medicare, Services, Centers for Disease Control, American Health Care Association, National Center for, Ethiopian, Tiksa, Reuters, Vaccine Alliance, World Health Organization, Coalition for, Health, United, Melinda Gates Foundation, Mastercard, Visa Foundation, European Investment Bank, African Union, Pfizer, National Advisory, AstraZeneca, Moderna, Astra Locations: Worthington, Pa, United States, Chicago and Kentucky, Addis Ababa, Ethiopia, Tiksa Negeri, Belgium, Denmark, Japan, Spain, Sweden, Australia, France, Kuwait, Mauritius, Mexico, Switzerland, Vietnam, Canada, Finland, Germany, Norway
Marcos Elihu Castillo Ramirez | iStock | Getty ImagesMedicare may not be top of mind if you're nearing the eligibility age of 65 and already have health insurance through your employer. While not everyone must sign up, many are required to enroll unless they want to face life-lasting late-enrollment penalties. The nuts and boltsOriginal, or basic, Medicare consists of Part A (hospital coverage) and Part B (outpatient care coverage). The remaining beneficiaries stick with basic Medicare and may pair it with a so-called Medigap policy and a standalone Part D plan. Many people with large group health insurance delay Part B but sign up for Part A because it's free.
Persons: Marcos Elihu Castillo Ramirez, Danielle Roberts, Roth, Roberts, Elizabeth Gavino, Gavino Organizations: iStock, Getty, Finance, Bureau of Labor Statistics, Medicare, Lewin
Total: 25